We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

67 hedge funds and large institutions have $42.1M invested in Zynerba Pharmaceuticals, Inc in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more capital invested

Capital invested by funds: $21.6M → $42.1M (+$20.5M)

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

73% more call options, than puts

Call options by funds: $4.74M | Put options by funds: $2.74M

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

16% more funds holding

Funds holding: 58 → 67 (+9)

Holders
67
Holders Change
+9
Holders Change %
+15.52%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
20
Reduced
12
Closed
10
Calls
$4.74M
Puts
$2.74M
Net Calls
+$2M
Net Calls Change
+$1.66M

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$4.2M
2
IEFM
IQ EQ Fund Management
Ireland
+$2.94M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.22M
4
PCM
Penserra Capital Management
California
+$1.03M
5
BlackRock
BlackRock
New York
+$857K

Top Sellers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$1.61M
2
Renaissance Technologies
Renaissance Technologies
New York
-$475K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$426K
4
LSA
Leonteq Securities AG
Switzerland
-$322K
5
SC
Sculptor Capital
New York
-$271K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
51
Spire Wealth Management
Virginia
$3K +$2.73K +602 New
Barclays
52
Barclays
United Kingdom
$3K +$3.33K +734 +14,680%
NFG
53
Next Financial Group
Texas
$2K -$6.35K -1,400 -72%
Citigroup
54
Citigroup
New York
$2K -$2.27K -500 -50%
PWMG
55
Prestige Wealth Management Group
New Jersey
$2K – – –
FCM
56
Firestone Capital Management
Florida
$2K +$2.27K +500 New
SIS
57
Sound Income Strategies
Florida
$1.63K – – –
IF
58
Ironwood Financial
Arizona
$1K +$535 +118 New
MWP
59
Meridian Wealth Partners
Pennsylvania
$1K +$644 +142 New
WAP
60
Wealthcare Advisory Partners
Pennsylvania
$1K +$657 +145 New
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$74 – – –
Renaissance Technologies
62
Renaissance Technologies
New York
– -$475K -144,000 Closed
SC
63
Sculptor Capital
New York
– -$271K -82,100 Closed
SFI
64
Susquehanna Fundamental Investments
Pennsylvania
– -$90K -27,336 Closed
Qube Research & Technologies (QRT)
65
Qube Research & Technologies (QRT)
United Kingdom
– -$87K -26,327 Closed
PP
66
PDT Partners
New York
– -$59K -17,927 Closed
SFS
67
Sowell Financial Services
Arkansas
– -$56.8K -12,535 -100%
ASN
68
Advisory Services Network
Georgia
– -$12K -3,600 Closed
FCMT
69
Founders Capital Management (Texas)
Texas
– -$18K -2,000 Closed
PFO
70
Pathstone Family Office
New Jersey
– -$3K -1,000 Closed
RWA
71
Ropes Wealth Advisors
Massachusetts
– -$3K -1,000 Closed
Toronto Dominion Bank
72
Toronto Dominion Bank
Ontario, Canada
– -$1K -192 Closed
HPC
73
HM Payson & Co
Maine
– +$227 +50 New
Fidelity Investments
74
Fidelity Investments
Massachusetts
– +$453 +100 New
HI
75
Harbour Investments
Wisconsin
– +$453 +100 New
1 2
3

ZYNE Hedge Fund Activity: Q1 2021 in Review

67 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q1 2021, worth a combined $42.1M — up 95% from $21.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ZYNE positions and 10 closed out — a net gain of 9 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $4.2M. The largest seller was Mirae Asset Global Investments, cutting an estimated $1.61M.

  • 67 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q1 2021, up from 58 in Q4 2020.
  • Funds reported $42.1M of Zynerba Pharmaceuticals, Inc stock for Q1 2021, up 95% quarter-over-quarter.
  • 19 funds opened new Zynerba Pharmaceuticals, Inc positions in Q1 2021 and 10 closed out, a net change of +9 holders.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q1 2021 was AdvisorShares Investments, an estimated $4.2M added.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q1 2021 was Mirae Asset Global Investments, an estimated $1.61M sold.

Based on aggregated 13F filings for Q1 2021.